The Levinson building?
Executive Summary
As part of the $200 mil. settlement between Genentech and the University of California-San Francisco over patents on recombinant human growth hormone, Genentech will contribute $50 mil. towards the construction of the first biological sciences research building on the new UCSF Mission Bay campus. Genentech will have the rights to name the building. The agreement provides $35 mil. in additional funding to UCSF and $30 mil. to the University of California general fund. Five researchers will share the remaining $85 mil. Genentech CEO Arthur Levinson, PhD, was a postdoctoral fellow at UCSF